Literature DB >> 15372116

Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy.

Maria Pina Dore1, Daniela Mura, Stefania Deledda, Emmanouil Maragkoudakis, Antonella Pironti, Giuseppe Realdi.   

Abstract

BACKGROUND & AIM: The relationship between Helicobacter pylori infection and peptic ulcer disease in cirrhosis remains controversial. The purpose of the present study was to investigate the role of H pylori infection and portal hypertension gastropathy in the prevalence of active peptic ulcer among dyspeptic patients with compensated hepatitis C virus (HCV)-related cirrhosis.
METHODS: Patients undergoing upper endoscopy with compensated HCV-related cirrhosis were enrolled. Child-Pugh's score was determined at the entry. Variceal size was measured endoscopically and the severity of portal hypertensive gastropathy was graded. H pylori infection status was determined by urea breath testing and/or histology.
RESULTS: A total of 178 patients positive for HCV (A and B Child-Pugh's score) were prospectively included. The prevalence of H pylori infection was 43%. An active peptic ulcer was found in 14 patients (8%) and was significantly more common among those with H pylori infection (16% versus 2% in H pylori uninfected patients, odds ratio: 8.0). No association was observed between H pylori infection and variceal size, or hypertensive gastropathy.
CONCLUSIONS: Patients with compensated cirrhosis and H pylori infection showed higher risk of developing a peptic ulcer. Clinical relevance of this result would be that dyspeptic patients with HCV-related cirrhosis may benefit from preventive screening and eradication of H pylori, especially those with features of insufficient hemostasis.

Entities:  

Mesh:

Year:  2004        PMID: 15372116     DOI: 10.1155/2004/150674

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  6 in total

1.  Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.

Authors:  Robert J Fontana; Arun J Sanyal; Marc G Ghany; Herbert L Bonkovsky; Timothy R Morgan; Heather J Litman; Andrea E Reid; William M Lee; Deepa Naishadham
Journal:  Am J Gastroenterol       Date:  2010-12-07       Impact factor: 10.864

2.  Helicobacter pylori Infection in Cirrhotic Patients With Portal Hypertensive Gastropathy: A New Enigma?

Authors:  Sumaiah J Alarfaj; Sally Abdallah Mostafa; Ramy A Abdelsalam; Walaa A Negm; Thanaa A El-Masry; Ismail A Hussein; Ahmed Mohamed El Nakib
Journal:  Front Med (Lausanne)       Date:  2022-06-17

Review 3.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 4.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

5.  Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis.

Authors:  Dong Joon Kim; Hak Yang Kim; Sung Jung Kim; Tae Ho Hahn; Myoung Kuk Jang; Gwang Ho Baik; Jin Bong Kim; Sang Hoon Park; Myung-Seok Lee; Choong Kee Park
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

6.  Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels.

Authors:  Zaigham Abbas; Javed Yakoob; Muhammad W Usman; Tanzila Shakir; Saeed Hamid; Wasim Jafri
Journal:  Saudi J Gastroenterol       Date:  2014 Mar-Apr       Impact factor: 2.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.